FOXO1 regulates the expression of several enzymes involved in gluconeogenesis and FOXO1 mRNA levels have been shown to correlate with the severity of NASH[8]. This evidence concerns the gene FOXO1 and metabolic dysfunction-associated steatohepatitis.